Trinity Biotech plc - American Depositary Shares (TRIB) analyst actions
Rating and price-target actions on TRIB in the public-source dataset. Wires and filings carry few rating actions, so this list is sparse by nature — the hub's by-event-type table holds the measured analyst base rates. Back to the TRIB overview →
1 measured TRIB analyst action event.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Trinity Biotech Announces Q1 2024 Financial Results and Reiterates Guidance | Press release | — | +3.17% |
Keep exploring
More TRIB: earnings → · SEC filings → · TRIB overview →
Other Healthcare names and their analyst actions
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Amphastar Pharmaceuticals, Inc. (AMPH) | 293 | +0.08% | 52% |
| Merus N.V. - Common Shares (MRUS) | 292 | +0.03% | 54% |
| CRISPR Therapeutics AG - Common Shares (CRSP) | 291 | +0.10% | 53% |
| Seres Therapeutics, Inc. (MCRB) | 290 | -0.23% | 46% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its analyst actions — that is what the link opens.